Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$1.59 - $2.73 $13,899 - $23,865
-8,742 Reduced 49.64%
8,868 $19,000
Q3 2023

Nov 13, 2023

BUY
$1.9 - $3.05 $33,459 - $53,710
17,610 New
17,610 $50,000
Q1 2021

May 11, 2021

SELL
$3.94 - $7.09 $2.23 Million - $4.02 Million
-566,314 Closed
0 $0
Q4 2020

Feb 11, 2021

BUY
$5.45 - $8.65 $978,983 - $1.55 Million
179,630 Added 46.45%
566,314 $3.4 Million
Q3 2020

Nov 09, 2020

SELL
$4.34 - $11.43 $4.1 Million - $10.8 Million
-945,502 Reduced 70.97%
386,684 $2.87 Million
Q2 2020

Aug 12, 2020

SELL
$1.85 - $5.29 $385,817 - $1.1 Million
-208,550 Reduced 13.54%
1,332,186 $5.35 Million
Q1 2020

May 11, 2020

SELL
$1.24 - $4.35 $182,211 - $639,210
-146,945 Reduced 8.71%
1,540,736 $3.91 Million
Q4 2019

Feb 06, 2020

BUY
$2.3 - $5.12 $959,852 - $2.14 Million
417,327 Added 32.85%
1,687,681 $5.87 Million
Q3 2019

Nov 07, 2019

BUY
$4.63 - $12.15 $998,274 - $2.62 Million
215,610 Added 20.44%
1,270,354 $5.88 Million
Q2 2019

Aug 08, 2019

BUY
$11.49 - $14.17 $2.4 Million - $2.96 Million
208,982 Added 24.71%
1,054,744 $13 Million
Q1 2019

May 09, 2019

BUY
$8.47 - $14.36 $2.6 Million - $4.41 Million
307,013 Added 56.99%
845,762 $11.2 Million
Q4 2018

Feb 07, 2019

BUY
$7.18 - $8.83 $450,085 - $553,517
62,686 Added 13.17%
538,749 $4.64 Million
Q3 2018

Oct 30, 2018

BUY
$5.92 - $8.35 $295,834 - $417,266
49,972 Added 11.73%
476,063 $3.57 Million
Q2 2018

Jul 24, 2018

BUY
$4.86 - $6.24 $606,080 - $778,177
124,708 Added 41.38%
426,091 $2.54 Million
Q1 2018

Apr 12, 2018

BUY
$5.75 - $7.97 $889,398 - $1.23 Million
154,678 Added 105.43%
301,383 $1.76 Million
Q4 2017

Jan 18, 2018

BUY
$4.46 - $6.45 $266,881 - $385,961
59,839 Added 68.89%
146,705 $864,000
Q3 2017

Oct 13, 2017

BUY
$3.55 - $5.49 $308,374 - $476,894
86,866
86,866 $438,000

Others Institutions Holding LAB

About STANDARD BIOTOOLS INC.


  • Ticker LAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 78,654,800
  • Market Cap $91.2M
  • Description
  • Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...
More about LAB
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.